Peter Lahajnar

Vision 20/20 – what is it all about?
||,
It is the end of February and the first 2 months of 2020 have already passed so it might be the right time to discuss the analogy between the year 2020 and vision. What is the fuss about 20/20 then?...
continue reading
AmblyoPlay received the Audience Award at Health Venture Lab
||
AmblyoPlay is the recipient of the prestigious Audience Award from Health Venture Lab in Budapest, Hungary. It has been voted as the most convincing of all digital business companies within the program. Health Venture Lab is a joint GE Healthcare and EIT Health incubation program for digital health startups...
continue reading
VISIT US AT VISION EXPO WEST IN LAS VEGAS!
||,
Following our official launch to the U.S. market last week, we are continuing the process of becoming a household name for the field of vision therapy in the U.S. by exhibiting at largest and most important optical exhibition in the...
continue reading
AmblyoPlay Vision Therapy for Lazy Eye available in the U.S.
||,
SAN FRANCISCO – Aug. 27, 2019 – AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or turned eye) or convergence insufficiency (eyes unable to focus together), today announces the launch of its software-based...
continue reading
AmblyoPlay recognized by GE Healthcare and EIT Health
||,
AmblyoPlay, the award-winning vision therapy solution for children with lazy eye, has been recognized by General Electrics Healthcare division (GE HealthCare) and European Institute of Innovation & Technology – Health (EIT Health). Smart Optometry – the team behind AmblyoPlay – has been invited to...
continue reading
Vision therapy at ARVO 2019
||, ,
Last week, one of our representatives took part at the largest annual meeting about the research in ophthalmology and visual science, ARVO 2019 meeting (The Association for Research in Vision and Ophthalmology). There, he presented his latest research work that has been...
continue reading